新春伊始,老挝东盟制药(TLPH)再添血液新药——莫洛替尼(Momelotinib),这是东盟制药在血液病治疗领域获批的第12款产品。 东盟制药的莫洛替尼(Momelotinib ...
As of 11:53:54 AM EST. Market Open. Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果